Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Marizyme Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
MRZM
Over the counter
8731
https://marizyme.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Marizyme Inc
Marizyme Inc CEO releases corporate update including details of key progress on DuraGraft
- Oct 30th, 2023 7:23 pm
Marizyme CEO Delivers Business Update
- Oct 23rd, 2023 1:00 pm
InvestmentPitch Media Video Features Marizyme's CEO David Barthel Discussing Receipt of FDA Clearance for its Flagship DuraGraft Medical Device
- Oct 13th, 2023 10:00 am
The Watchlist by The Market Herald Releases New Interviews with Marizyme, Regenx, BuildDirect, and Three Sixty Solar Discussing Their Latest News
- Oct 6th, 2023 8:00 pm
Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™
- Oct 6th, 2023 1:00 pm
Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products
- May 10th, 2023 12:00 pm
Scroll